Regeneron Pharmaceuticals (NQ: REGN )
1,179.31
+3.98
(+0.34%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
All News about Regeneron Pharmaceuticals
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/04/11/REGN.png?width=1200&height=800&fit=crop)
Eye Drug Eylea Price Manipulation: Regeneron Faces US Justice Department Allegations Over Medicare Pricing Of Its Best-Selling Eye Drug
April 11, 2024
Via Benzinga
Topics
Fraud
Exposures
Legal
![](https://ml.globenewswire.com/media/60f84371-8ef5-454a-ab60-63e56a837741/small/schall-firm-logo-2-jpg.jpg)
![](https://www.investors.com/wp-content/uploads/2020/08/Stock-regeneron-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
Via GlobeNewswire
![](https://g.foolcdn.com/editorial/images/770862/physician-talking-to-patient.jpg)
![](https://investorplace.com/wp-content/uploads/2019/09/pills-1.jpg)
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2024/03/TECHpic-brain-040124-shutt.jpg)
![](https://g.foolcdn.com/editorial/images/770130/physician-talking-to-patient.jpg)
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/cancer_16.jpeg?width=1200&height=800&fit=crop)
FDA Delays Decision For Regeneron's Inaugural Blood Cancer Therapy, Highlights Trial Concerns
March 25, 2024
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/biotech_bigpharma1600.png)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/03/13/nvidia_2_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
![](https://g.foolcdn.com/editorial/images/768349/scientists-looking-at-screen-with-icons.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/767744/doctor-and-patient-in-a-hospital-room.jpg)
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.